๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease

โœ Scribed by J. Eric Ahlskog; Ryan J. Uitti; Michael K. O'Connor; Demetrius M. Maraganore; Joseph Y. Matsumoto; Kathy F. Stark; Margaret F. Turk; Omer L. Burnett


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
87 KB
Volume
14
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Increased expression of dopamine recepto
โœ Piero Barbanti; Giovanni Fabbrini; Alberto Ricci; Rosanna Cerbo; Elena Bronzetti ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 118 KB ๐Ÿ‘ 1 views

Dopamine D1-like and D2-like receptors on peripheral blood lymphocytes (PBL) were assayed in 50 de novo patients with idiopathic Parkinson's disease (PD), in 36 neurologic control subjects (multiple-system atrophy, n โ€ซืกโ€ฌ 16; essential tremor, n โ€ซืกโ€ฌ 10; other neurodegenerative diseases, n โ€ซืกโ€ฌ 10), an

Altropane, a SPECT or PET imaging probe
โœ Bertha K. Madras; Lawrence M. Gracz; Michele A. Fahey; David Elmaleh; Peter C. M ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 362 KB ๐Ÿ‘ 2 views

Increasing evidence suggests that the dopamine transporter is situated almost exclusively on dopamine neurons. Accordingly, it is an valuable marker for Parkinson's disease and other pathological states of dopamine neurons. We previously demonstrated that the potent dopamine transport inhibitor [ 12